Jan 14, 2025, 08:20 by

Caidya today announced the closing of a strategic growth investment of $165 million from funds managed by Rubicon Founders.

Jan 14, 2025, 01:00 by User Not Found

Clinical Research News | Widespread misinformation about what obesity is and how it should be treated is finally getting the attention it deserves. The inconvenient truth is that obesity is a series of diseases, and the underlying culprit is malfunctioning adipose tissue.

Jan 13, 2025, 09:00 by User Not Found

Clinical Research News | Among the many partnerships and technical announcements made by NVIDIA during the company's Monday morning presentation at the 43rd Annual J.P. Morgan Healthcare Conference, NVIDIA focused several on innovation within the healthcare and life sciences industry.

Jan 13, 2025, 08:15 by

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in vivo B-cell maturation antigen (BCMA) CAR-T candidate to reach the clinical stage and utilises a synthetic promoter designed using Chromatin Bio’s proprietary promoter design platform, chromatinLENS, exclusively for EsoBiotec as part of its innovative approach to immunotherapy.

Jan 10, 2025, 08:29 by

Coronado Research is pleased to announce the appointment of Jo Marshall as EVP of Data Services and Advanced Analytics.

Jan 10, 2025, 08:29 by

Biofidelity and CellCarta have announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials.

Jan 10, 2025, 08:29 by

STEMart introduces Balloon Catheter Testing Services for the development of safe and effective medical devices.

Jan 10, 2025, 08:29 by

Jan 9, 2025, 08:26 by

PrecisionLife announces the appointment of Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare.

Jan 9, 2025, 01:00 by User Not Found

Clinical Research News | Finalists have been named in two of the three awards programs slated for the SCOPE Summit, February 3-6, in Orlando, Fla. Entries in the Participant Engagement Awards and the Site Innovation Awards have been named finalists. Winners will be announced on site at the event.

Jan 8, 2025, 07:54 by

ClearNote Health announced that its Avantect Multi-Cancer Detection Test was selected for the National Cancer Institute’s new Vanguard Study.

Jan 8, 2025, 07:54 by

Following an expanded collaboration between AI innovator Quris-AI and Merck KGaA and a two-year validation study to test clinical safety prediction by identifying drug candidate liver toxicity risks, it was announced this morning that Merck KGaA has adopted the startup's platform to test small molecule drug candidates prior to initiating clinical trials. Quris-AI’s platform integrates advanced AI, machine learning, generative models, patient-on-chip technology, and proprietary data to predict potential drug-induced toxicities better.

Jan 7, 2025, 08:29 by

ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry.

Jan 7, 2025, 08:29 by

IDDI, a Belgium-based clinical research service provider with a U.S. office in Raleigh, NC, has announced significant changes to its executive leadership team. Tim Davis has been appointed as CEO, bringing over 25 years of expertise in pharmaceuticals, life sciences, and digital health. Jeremy Edwards has been named the new Chief Commercial Officer at IDDI bringing 27 years of experience across the clinical development continuum. Davis and Edwards’ combined expertise will strengthen IDDI’s operational excellence and patient-centric solutions. The new leadership positions IDDI for growth, focusing on delivering integrated patient-relevant outcomes across clinical trial phases for clients in the USA and Europe. www.iddi.com

Jan 7, 2025, 01:00 by User Not Found

Clinical Research News | 2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to expect in the new year. Here are the full predictions and trends, including more information on patient recruitment and retention, patient perspectives in clinical trials, AI/ML’s impact on drug development, and more.

Jan 3, 2025, 01:00 by User Not Found

Clinical Research News | In 2024, AI continued to help clinical research and trials by increasing efficiency and patient engagement, new drugs and treatments showed great potential for previously difficult-to-treat diseases, and decentralized clinical trials are heading to their “next phase.” The Scope of Things podcast also delivered news and exclusive conversations on improving diversity in clinical trials, enrollment challenges, patient centricity, and more. To kick off 2025, here are the top stories from Clinical Research News and top episodes from the Scope of Things podcast.

Dec 30, 2024, 01:00 by User Not Found

Clinical Research News | We have all heard it often noted that treatment outcomes in real-world practice don't always reflect those observed in clinical trials, largely attributing these differences to a lack of adherence to prescribed therapy. Yet the uncomfortable truth is that therapeutic nonadherence happens in clinical trials too—with far-reaching consequences.

Dec 27, 2024, 01:00 by User Not Found

Clinical Research News | myTomorrows adds the ISRCTN registry to the clinical trial search functionality on its platform; Mission Bio collaborates with University of Miami on Multiple Myeloma (MM) at an unprecedented level of clonal detail; and more.

Dec 23, 2024, 08:28 by User Not Found

Clinical Research News | Nuvig aims to deliver novel methods for reducing autoimmune dysregulation without immunosuppression; Noema Pharma plans to advance four active Phase 2 trials for trigeminal neuralgia, tuberous sclerosis complex, and other diseases; and more.

Dec 19, 2024, 11:12 by

ClearNote Health's Avantect Pancreatic Cancer test was selected for a large UK NHS study that will include up to 15,000 patient participants recently diagnosed with type 2 diabetes. The Avantect test is a blood-based assay designed to use key epigenomic and genomic signals to detect the earliest indicators of pancreatic cancer.